首页> 外国专利> SOLID LIPID COMPOSITIONS OF LIPOPHILIC COMPOUNDS FOR ENHANCED ORAL BIOAVAILABILITY

SOLID LIPID COMPOSITIONS OF LIPOPHILIC COMPOUNDS FOR ENHANCED ORAL BIOAVAILABILITY

机译:增强口服生物利用度的脂类化合物的固体脂质成分

摘要

A dry solid lipidic composition comprising: a first component of a lipophilic substance selected from the group consisting of a cannabinoid, a steroid, a steroid antagonist, a non-steroidal antiinflammatory agent, an antifungal agent, an antibacterial agent, an antihypertensive agent, an anti-oxidant, an anti-epileptic agent, an antiviral agent, an anticancer agent, and an antidepressant in an amount of about 0.01 to 50% by weight of the lipidic composition to provide a therapeutic effect when administered to a mammal; a second component comprising at least one fat which is a solid at about 25!C and which is present in an amount of about 20 to 75% of the weight of the lipidic composition; and a third component of at least one phospholipid which is present in an amount of about 2 to 40% by weight of the lipidic composition, with these three components totaling 100% of the lipidic composition, wherein the second and third components increase the oral availability of the lipophilic substance when administered to the mammal. 1334 א' בתמוז התשס" ד - June 20, 2004
机译:一种干燥的固体脂质组合物,其包含:亲脂性物质的第一组分,所述第一组分选自大麻素,类固醇,类固醇拮抗剂,非类固醇抗炎剂,抗真菌剂,抗菌剂,抗高血压剂,抗氧化剂,抗癫痫药,抗病毒药,抗癌药和抗抑郁药的量为脂质组合物的约0.01至50重量%,当施用于哺乳动物时可提供治疗效果;第二组分,其包含至少一种脂肪,该脂肪在约25℃下为固体,并且以脂质组合物的重量的约20至75%的量存在;以及至少一种磷脂的第三组分,其含量为脂质组合物重量的约2%至40%,这三种组分总计占脂质组合物的100%,其中第二组分和第三组分增加了口服利用率当施用给哺乳动物时,亲脂性物质的量为0。 1334א'בתמוזהתשס"תשס-2004年6月20日

著录项

  • 公开/公告号IL126384B

    专利类型

  • 公开/公告日2004-06-20

    原文格式PDF

  • 申请/专利权人 SHIMON AMSELEM;PHARMOS CORPORATION;

    申请/专利号IL126384

  • 发明设计人 SHIMON AMSELEM;

    申请日1997-04-02

  • 分类号A61K9/127;

  • 国家 IL

  • 入库时间 2022-08-21 23:10:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号